BRANFORD, Conn., Oct. 13 /PRNewswire-FirstCall/ -- CAS Medical Systems, Inc. has been named to Deloitte’s Technology Fast 50 Program for the Connecticut Region, a ranking of the 50 fastest growing technology companies in the area by Deloitte & Touche USA LLP, one of the nation’s leading professional services organizations. Rankings are based on the percentage of revenue growth over five years from 2001-2005.
CASMED’s CEO, Louis P. Scheps, attributes the Company’s 82% revenue growth from 2001-2005 to new product introductions, a focus on continuous improvements and quality, and strengthening of the management team. “We are proud to be named to the Fast 50 for a fifth consecutive year,” stated Mr. Scheps. “CASMED’s strong growth has been led by our vital signs monitoring products and our non-invasive blood pressure technology. Our complete line of patient monitors using best-in-class technologies has been well accepted in our target markets and our proprietary MAXNIBP(R) blood pressure technology has continued to grow with new OEM partnerships worldwide. In addition to growing our core businesses, we are focused on the introduction later this year of our new FORE-SIGHT(TM) Cerebral Oximeter product which will allow clinicians to monitor and quickly respond to instances of brain tissue oxygen deprivation before damage to the brain occurs.”
To qualify for the Connecticut Technology Fast 50, companies must have had operating revenues of at least $50,000 in 2001 and $5,000,000 in 2005, be headquartered in Connecticut, and be a company that owns proprietary technology or proprietary intellectual property that contributes to a significant portion of the company’s operating revenues; or devotes a significant proportion of revenues to the research and development of technology. Using other companies’ technology or intellectual property in a unique way does not qualify.
“Sustaining high revenue growth over five years is an exceptional accomplishment,” stated Alex Discepolo, Director Lead Tax Services, Deloitte Tax LLP. “We commend CAS Medical Systems, Inc. for making the commitment to the technology sector in the Connecticut Region. We are proud to announce CASMED as a Deloitte Technology Fast 50 winner.”
Winners of the 16 regional Technology Fast 50 programs in the United States and Canada are eligible to be entered into Deloitte’s Technology Fast 500 program, which ranks North America’s top 500 fastest growing technology, media, telecommunications and life sciences companies. For more information on Deloitte’s Technology Fast 50 or Technology Fast 500 programs, visit http://www.fast500.com.
About CAS Medical Systems, Inc. - CASMED(TM)
Founded in 1984, CAS Medical Systems, Inc. is dedicated to the design and manufacture of innovative technologies and products vital to patient care in the most challenging clinical environments. Its current product lines include blood pressure measurement technology, vital signs monitoring equipment, flood pressure cuffs, apnea monitoring equipment and products for neonatal intensive care. With a reputation for the highest quality products available in the markets it serves, CASMED products are used by clinicians worldwide.
About Deloitte
Deloitte refers to one or more of Deloitte Touche Tohmatsu, as Swiss Verein, its member firms and their respective subsidiaries and affiliates. As a Swiss Verein (association), neither Deloitte Touche Tohmatsu nor any member firms has any liability for each other’s acts or omissions. Each of the member firms is a separate and independent legal entity operating under the names “Deloitte,” “Deloitte & Touche,” “Deloitte Touche Tohmatsu” or other related names. Services are provided by the member firms or their subsidiaries or affiliates and not by the Deloitte Touche Tohmatsu Verein.
Deloitte & Touche USA LLP is the US member firm of Deloitte Touche Tohmatsu. In the US, services are provided by the subsidiaries of Deloitte & Touche USA LLP (Deloitte & Touche LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, Deloitte Tax LLP and their subsidiaries, and not by Deloitte & Touche USA LLP.
For more information contact: CAS Medical Systems, Inc. 44 East Industrial Road Branford, CT 06405 (203) 488-6056 ir@casmed.com Investors Media Financial Dynamics Financial Dynamics John Capodanno Robert Stanislaro 212-850-5705 212-850-5657 jcapodanno@fd-us.comrstanislaro@fd-us.com
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technical difficulties, and other risks detailed in the Company’s Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms “anticipate,” “believe,” “estimate,” “expect,” “may,” “objective,” “plan,” “possible,” “potential,” “project,” “will” and similar expressions identify forward- looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.
CAS Medical Systems, Inc.
CONTACT: Investors - John Capodanno, +1-212-850-5705,jcapodanno@fd-us.com, or Media - Robert Stanislaro, +1-212-850-5657,rstanislaro@fd-us.com, both of Financial Dynamics
Web site: http://www.casmed.com/
